未登录
分享
收藏Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia马来西亚180天内尼马曲韦/利托那韦治疗和COVID后病情的风险
Low, Ee Vien; Pathmanathan, Mohan Dass; Ten, Yi Yang; Chidambaram, Suresh Kumar; Kim, Wee Ric; Lee, Wei Jia; Teh, Zhi Wei; Appannan, Maheshwara Rao; Ismail, Mastura; Samad, Azah Abdul; Peariasamy, Kalaiarasu M.
分享
收藏
分享
收藏Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months
Low, Ee Vien; Tok, Peter Seah Keng; Husin, Masliyana; Suah, Jing Lian; Tng, Boon Hwa; Thevananthan, Thevesh; Appannan, Maheshwara Rao; Yahaya, Hazlina; Zin, Shahanizan Mohd; Zin, Faizah Muhamad; Sivasampu, Sheamini; Peariasamy, Kalaiarasu M.
分享
收藏PICK-ing Malaysia's Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio挑选马来西亚的流行病: 多样化新型冠状病毒肺炎疫苗组合的有效性
Suah, Jing Lian; Tok, Peter Seah Keng; Ong, Su Miin; Husin, Masliyana; Tng, Boon Hwa; Sivasampu, Sheamini; Thevananthan, Thevesh; Appannan, Maheshwara Rao; Muhamad Zin, Faizah; Mohd Zin, Shahanizan; Yahaya, Hazlina; Rusli, Norhayati; Ujang, Mohd Fikri; Mohd Ibrahim, Hishamshah; Abdullah, Noor Hisham; Peariasamy, Kalaiarasu M.
分享
收藏